Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Genome-wide association is a promising approach to identify common genetic variants that predispose to human disease. Because of the high cost of genotyping hundreds of thousands of markers on thousands of subjects, genome-wide association studies often follow a staged design in which a proportion (pi(samples)) of the available samples are genotyped on a large number of markers in stage 1, and a proportion (pi(samples)) of these markers are later followed up by genotyping them on the remaining samples in stage 2. The standard strategy for analyzing such two-stage data is to view stage 2 as a replication study and focus on findings that reach statistical significance when stage 2 data are considered alone. We demonstrate that the alternative strategy of jointly analyzing the data from both stages almost always results in increased power to detect genetic association, despite the need to use more stringent significance levels, even when effect sizes differ between the two stages. We recommend joint analysis for all two-stage genome-wide association studies, especially when a relatively large proportion of the samples are genotyped in stage 1 (pi(samples) >or= 0.30), and a relatively large proportion of markers are selected for follow-up in stage 2 (pi(markers) >or= 0.01).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Joint analyses provide more statistical power than the power that meta-analysis approaches (Skol, et al., 2006)”
From A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin (2016) · cites this paper as Skol, et al., 2006
In the citing paper
“Post-hoc power analysis was performed for odds ratios ranging from 1.05 to 1.30 and across allele frequencies using CaTS61 with the estimated effective sample size.”
From Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) · cites this paper as [61]
In the citing paper
“Using equations from Wray et al. 2010 and our current heritability estimates, the 88 variant PRS explained a minimum 16% of the genetic liability of PD assuming a global prevalence of 0.5% (2,31).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
In the citing paper
“In a high-risk population with a prevalence of 2%, the 1805 variant PRS explained a maximum 36% of PD heritable risk (2,31) (Table S4).”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
In the citing paper
“maximum potential AUC estimated at 85% using the equations from Wray et al. 2010”
From Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies (2019) · cites this paper as [31]
Citations
Cites
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
Self-citationThe Future of Genetic Studies of Complex Human Diseases
Risch, N., & Merikangas, K. (1996) · Science · doi:10.1126/science.273.5281.1516 · Cited by 5,355 · cited 1×
“Note that equation (1) allows evidence for association to be combined without assuming equal effect sizes and allele frequencies for the two stages.”
BackgroundComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
The International SNP Map Working Group, Laboratories:, C. S. H., Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., National Center for Biotechnology Information:, Marth, G., Sherry, S., et al. (2001) · Nature · doi:10.1038/35057149 · Cited by 2,977 · cited 1×
“, enabled by rapidly decreasing genotyping costs, massively multiplexed genotyping technologies and the large-scale SNP discovery and genotyping efforts of the SNP Consortiu”
BackgroundGenome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,863 · cited 1×
“The false positive rate corresponding to thresholds C1 and Cjoint is amarker 1⁄4 P(|z1| 4 C1 AND |zjoint| 4 Cjoint) 1⁄4 P(|z1| 4 C1) P(|zjoint| 4 Cjoint | |z1| 4 C1), which can be calculated numerically by evaluating a simple integral (see equation (2) below).”
BackgroundProspects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416
Association study designs for complex diseases
Cardon, L. R., & Bell, J. I. (2001) · Nature Reviews Genetics · doi:10.1038/35052543 · Cited by 1,395
Haplotype tagging for the identification of common disease genes
Johnson, G. C. L., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-233 · Cited by 1,174
Whole-Genome Patterns of Common DNA Variation in Three Human Populations
Hinds, D. A., Stuve, L. L., Nilsen, G. B., Halperin, E., Eskin, E., Ballinger, D. G., Frazer, K. A., & Cox, D. R. (2005) · Science · doi:10.1126/science.1105436 · Cited by 1,170
Genomic Control, a New Approach to Genetic-Based Association Studies
Devlin, B., Roeder, K., & Wasserman, L. (2001) · Theoretical Population Biology · doi:10.1006/tpbi.2001.1542 · Cited by 516
Cited by
Items 201–300 of 1,000
Exome Sequencing of Familial Bipolar Disorder
Goes, F. S., Pirooznia, M., Parla, J. S., Kramer, M., Ghiban, E., Mavruk, S., Chen, Y.-C., Monson, E. T., Willour, V. L., Karchin, R., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0251 · Cited by 115
Self-citationTeo, Y. Y. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f5dd77 · Cited by 126
Germain, M., Eyries, M., Montani, D., Poirier, O., Girerd, B., Dorfmüller, P., Coulet, F., Nadaud, S., Maugenre, S., Guignabert, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2581 · Cited by 120
Sinner, M. F., Pfeufer, A., Akyol, M., Beckmann, B.-M., Hinterseer, M., Wacker, A., Perz, S., Sauter, W., Illig, T., Näbauer, M., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm619 · Cited by 108
Knauff, E. A. H., Franke, L., van Es, M. A., van den Berg, L. H., van der Schouw, Y. T., Laven, J. S. E., Lambalk, C. B., Hoek, A., Goverde, A. J., Christin‐Maître, S., et al. (2009) · Human Reproduction · doi:10.1093/humrep/dep197 · Cited by 109
“A joint analysis (Skol et al., 2006) of Phases I and II using a Maentel–Haenszel test resulted in P ¼ 4.05 1025.”
InfluentialHighly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays
Macgregor, S., Zhao, Z. Z., Henders, A., Martin, N. G., Montgomery, G. W., & Visscher, P. M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1060 · Cited by 106
“(19); this can be achieved in two ways.”
BackgroundMethodInfluentialHettema, J. M., An, S., Bukszár, J., van den Oord, E. J. C. G., Neale, M. C., Kendler, K. S., & Chen, X. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.014 · Cited by 117
Zvinorova, P. I., Halimani, T. E., Muchadeyi, F. C., Matika, O., Riggio, V., & Dzama, K. (2016) · Veterinary Parasitology · doi:10.1016/j.vetpar.2016.05.015 · Cited by 125
Roeske, D., Ludwig, K. U., Neuhoff, N., Becker, J., Bartling, J., Bruder, J., Brockschmidt, F. F., Warnke, A., Remschmidt, H., Hoffmann, P., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2009.102 · Cited by 106
Martin, J.-E., Assassi, S., Diaz-Gallo, L.-M., Broen, J. C., Simeon, C. P., Castellvi, I., Vicente-Rabaneda, E., Fonollosa, V., Ortego-Centeno, N., González-Gay, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt248 · Cited by 105
Carmona, F. D., Vaglio, A., Mackie, S. L., Hernández‐Rodríguez, J., Monach, P. A., Castañeda, S., Solans, R., Morado, I. C., Narváez, J., Ramentol-Sintas, M., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.11.013 · Cited by 118
Sookoian, S. C., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., & Pirola, C. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.015 · Cited by 108
“05 [26] for HapMap-predicted MAF of 0.”
The genomic landscape of testicular germ cell tumours: from susceptibility to treatment
Litchfield, K., Levy, M., Huddart, R. A., SHIPLEY, J. M., & Turnbull, C. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2016.107 · Cited by 113
Gourh, P., Tan, F. K., Assassi, S., Ahn, C. W., McNearney, T. A., Fischbach, M., Arnett, F. C., & Mayes, M. D. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22196 · Cited by 102
Upward bias in odds ratio estimates from genome‐wide association studies
Garner, C. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20209 · Cited by 103
“…in GWA studies complicates the interpretation of the results, considerable research has gone into developing multistage approaches for validating or replicating statistical results [Lin, 2006; Satagopan and Elston, 2003; Satagopan et al., 2002, 2004; Skol et al., 2006; Thomas et al., 2004].”
Heinzen, E. L., Depondt, C., Cavalleri, G. L., Ruzzo, E. K., Walley, N. M., Need, A. C., Ge, D., He, M., Cirulli, E. T., Zhao, Q., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.016 · Cited by 103
“Power calculations were performed with the CaTS-Power Calculator.21 little power to achieve formal significance unless risk alleles were common and/or of major effect (Figure 2).”
MethodThe IMAGEN study: a decade of imaging genetics in adolescents
Mascarell-Maricic, L., Walter, H., Rosenthal, A., Ripke, S., Quinlan, E. B., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Bromberg, U., Büchel, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0822-5 · Cited by 111
Jungerius, B. J., Hoogendoorn, M. L. C., Bakker, S. C., Slot, R. V. ‘., Bardoel, A. F. J., Ophoff, R. A., Wijmenga, C., Kahn, R. S., & Sinke, R. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002080 · Cited by 109
Holmans, P. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380862-2.00007-2 · Cited by 109
Power analysis for genome-wide association studies
Klein, R. J. (2007) · BMC Genetics · doi:10.1186/1471-2156-8-58 · Cited by 116
“have proposed a method for computing power, though they were concerned with issues of study design rather than tag SNP choice [16].”
MethodGenome-Wide Diet-Gene Interaction Analyses for Risk of Colorectal Cancer
Figueiredo, J. C., Hsu, L., Hutter, C. M., Lin, Y., Campbell, P. T., Baron, J. A., Berndt, S. I., Jiao, S., Casey, G., Fortini, B. K., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004228 · Cited by 110
“In the present study, we did not divide our large sample into discovery and replication sets, as it has been shown that the most powerful analytical approach is a combined analysis across all studies [35].”
The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
Carmona, F. D., Martín, J., Beretta, L., Simeón‐Aznar, C. P., Carreira, P. E., Callejas-Rubio, J. L., Castro, M. F., Comet, L. S., Beltrán, E., Camps, M. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054419 · Cited by 101
“[16].”
Sookoian, S. C., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., Rosselli, M. S., & Pirola, C. J. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328333a1dd · Cited by 103
Statistical power in genome-wide association studies and quantitative trait locus mapping
Wang, M., & Xu, S. (2019) · Heredity · doi:10.1038/s41437-019-0205-3 · Cited by 109
Jaïs, J., Haïoun, C., Molina, T. J., Rickman, D. S., de Reyniès, A., Berger, F., Gisselbrecht, C., Brière, J., Reyes, F., Gaulard, P., et al. (2008) · Leukemia · doi:10.1038/leu.2008.188 · Cited by 109
“samples ( 27 , 28) and checked the results consistency by testing interaction terms between”
Yang, W., Ng, P. C., Zhao, M., Hirankarn, N., Lau, C. S., Mok, C. C., Chan, T. M., Wong, W. H. S., Lee, K. W., Mok, M. Y., et al. (2009) · Genes and Immunity · doi:10.1038/gene.2009.1 · Cited by 99
Association of SIRT1 gene variation with visceral obesity
Peeters, A. V., Beckers, S., Verrijken, A., Mertens, I. L., Roevens, P. W. M., Peeters, P. J., Hul, W. V., & Gaal, L. F. V. (2008) · Human Genetics · doi:10.1007/s00439-008-0567-8 · Cited by 107
“Power calculations were carried out with the CaTS power calculator (Skol et al. 2006).”
MethodHoppe, C., Klitz, W., D’Harlingue, K., Cheng, S., Grow, M., Steiner, L., Noble, J., Adams, R., & Styles, L. (2007) · Stroke · doi:10.1161/strokeaha.107.483115 · Cited by 93
A 100K Genome-Wide Association Scan for Diabetes and Related Traits in the Framingham Heart Study
Florez, J. C., Manning, A. K., Dupuis, J., McAteer, J., Irenze, K., Gianniny, L., Mirel, D. B., Fox, C. S., Cupples, L. A., & Meigs, J. B. (2007) · Diabetes · doi:10.2337/db07-0451 · Cited by 95
“This serial replication strategy yields equivalent power as the joint analysis when 1% of SNPs are promoted to the second stage (13).”
BackgroundMethodGenome-wide association with diabetes-related traits in the Framingham Heart Study
Meigs, J. B., Manning, A. K., Fox, C. S., Florez, J. C., Liu, C., Cupples, L. A., & Dupuis, J. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s16 · Cited by 98
“Resources are now becoming available to perform such genome-wide association (GWA) studies of type 2 diabetes [15-18].”
Eslam, M., McLeod, D. J., Kelaeng, K. S., Mangia, A., Berg, T., Thabet, K., Irving, W. L., Dore, G. J., Sheridan, D. A., Grønbæk, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3836 · Cited by 97
Successful design and conduct of genome-wide association studies
Amos, C. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm161 · Cited by 98
Wang, C., Yan, H., Li, J., Li, Z., Zhang, X., Ma, Y., Mei, L., Liu, C., Cai, L., Wang, Q., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.212 · Cited by 97
A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration
de Vries, P. S., Chasman, D. I., Sabater‐Lleal, M., Chen, M., Huffman, J. E., Steri, M., Tang, W., Teumer, A., Marioni, R. E., Grossmann, V., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv454 · Cited by 103
“To most effectively use the available data, we used all 34 studies in the discovery sample (33).”
MethodShen, G.-Q., Li, L., Girelli, D., Seidelmann, S. B., Rao, S., Fan, C., Park, J. E., Xi, Q., Li, J., Hu, Y., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521581 · Cited by 95
Liu, Y., Xu, H., Chen, S., Chen, X., Zhang, Z., Zhu, Z., Qin, X., Hu, L., Zhu, J. Z., Zhao, G., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001338 · Cited by 101
“This is similar to the ‘‘joint analysis’’ strategy [40] of single-locus analyses in GWAS.”
ResultUnderstanding Genetic Factors in Idiopathic Scoliosis, a Complex Disease of Childhood
Wise, C. A., Gao, X., Shoemaker, S., Gordon, D., & Herring, J. A. (2008) · Current Genomics · doi:10.2174/138920208783884874 · Cited by 109
“[89], although modified so that power is calculated for TDT rather than case-”
BackgroundAssociation Study of Nonsynonymous Single Nucleotide Polymorphisms in Schizophrenia
Carrera, N., Arrojo, M., Sanjuán, J., Ramos‐Ríos, R., Paz, E., Suárez‐Rama, J. J., Páramo, M., Agra, S., Brenlla, J., Martínez, S., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.032 · Cited by 97
Genetic Contributions to Clinical Pain and Analgesia: Avoiding Pitfalls in Genetic Research
Kim, H., Clark, J. D., & Dionne, R. A. (2009) · Journal of Pain · doi:10.1016/j.jpain.2009.04.001 · Cited by 104
“A suggested alternative approach is designing a study with multiple stages.(79,84) First, a relatively small number of samples, at least a few hundred, are used in a preliminary GWAS to identify 1 or 2 candidate genomic regions.”
Meng, W., Deshmukh, H. A., Donnelly, L. A., Torrance, N., Colhoun, H. M., Palmer, C. N. A., & Smith, B. H. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.001 · Cited by 88
“25, and the significance level is 10 (Skol et al., 2006).”
BackgroundInfluentialIgG4-related disease in the Japanese population: a genome-wide association study
Terao, C., Ôta, M., Iwasaki, T., Shiokawa, M., Kawaguchi, S., Kuriyama, K., Kawaguchi, T., Kodama, Y., Yamaguchi, I., Uchida, K., et al. (2019) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30006-2 · Cited by 93
Awata, T., Yamashita, H., Kurihara, S., Morita‐Ohkubo, T., Miyashita, Y., Katayama, S., Mori, K., Yoneya, S., Kohda, M., Okazaki, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111715 · Cited by 95
Testing association for markers on the X chromosome
Zheng, G., Joo, J., Zhang, C., & Geller, N. L. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20244 · Cited by 93
“In practice, however, the ABT is also often used [Klein et al., 2005; Skol et al., 2006].”
MethodImproving power in genome‐wide association studies: weights tip the scale
Roeder, K., Devlin, B., & Wasserman, L. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20237 · Cited by 96
Pirola, C. J., Scian, R., Gianotti, T. F., Dopazo, H., Rohr, C., Martino, J. S., Castaño, G. O., & Sookoian, S. C. (2015) · Medicine · doi:10.1097/md.0000000000001480 · Cited by 103
Kushima, I., Nakamura, Y., Aleksic, B., Ikeda, M., Ito, Y., Shiino, T., Okochi, T., Fukuo, Y., Ujike, H., Suzuki, M., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq118 · Cited by 92
“edu/csg/abecasis/ CaTS/).(24) Power was estimated under the following parameter assumptions with respect to association test statistics: genetic relative risk = 2, prevalence of disease = 0.”
MethodKerns, S. L., Dorling, L., Fachal, L., Bentzen, S. M., Pharoah, P. D. P., Barnes, D. R., Gómez‐Caamaño, A., Carballo, A. M., Dearnaley, D. P., Peleteiro, P., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.07.022 · Cited by 96
“The aimwas to show thatmulti-center radiotherapy cohorts could be harmonized and analyzed to identify risk SNPs by increasing the number of individuals analyzed in a single stage (Skol et al., 2006).”
BackgroundGenome-wide significance levels and weighted hypothesis testingPreprint
Roeder, K., & Wasserman, L. (2009) · Cited by 91
Evaluation of common genetic variants in 82 candidate genes as risk factors for neural tube defects
Pangilinan, F., Molloy, A. M., Mills, J. L., Troendle, J. F., Parle‐McDermott, A., Signore, C. C., O’Leary, V. B., Chines, P. S., Seay, J. M., Geiler‐Samerotte, K., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-62 · Cited by 94
“Rather than use the secondary samples for a replication study, joint analysis of the combined dataset was performed since it generally provides greater power to detect a genetic effect [57].”
BackgroundGayther, S. A., Song, H., Ramus, S. J., Kjær, S. K., Whittemore, A. S., Quaye, L., Tyrer, J. P., Shadforth, D., Høgdall, E. V. S., Høgdall, C. K., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3261 · Cited by 90
“a single, two-stage multicenter study rather than hypothesis-generating and replication studies because joint analysis has been shown to be more efficient than replication analysis in a staged design ( 34 ).”
BackgroundMethodMeng, W., Deshmukh, H. A., van Zuydam, N. R., Liu, Y., Donnelly, L. A., Zhou, K., Wellcome Trust Case Control Consortium 2 (WTCCC2), Surrogate Markers for Micro‐ and Macro‐Vascular Hard Endpoints for Innovative Diabetes Tools (SUMMIT) Study Group, Morris, A. D., Colhoun, H. M., et al. (2015) · European Journal of Pain · doi:10.1002/ejp.560 · Cited by 84
“According to CaTS, using a multiplicative model, we had 80% power to detect a genotypic relative risk of 1.44 (or 0.69) for variants with a minor allele frequency of 30% when the disease prevalence in the population is 10% and the significant level is 10−6 (Skol et al., 2006).”
InfluentialNewton‐Cheh, C., Guo, C., Wang, T. J., O’Donnell, C. J., Levy, D. A., & Larson, M. G. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s7 · Cited by 100
“Conclusion Staged GWAS designs in which a modest number of results from GWAS in the first stage are tested in a second independent sample and the combined statistical evidence considered, are powerful and efficient approaches to identify common variants associated with complex traits [29,30].”
Design of association studies with pooled or un‐pooled next‐generation sequencing data
Kim, S. Y., Li, Y., Guo, Y., Li, R., Holmkvist, J., Hansen, T., Pedersen, O., Wang, J., & Nielsen, R. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20501 · Cited by 89
“While the properties and design of the second stage have been explored extensively in the previous work [Skol et al., 2006; Zuo et al., 2008], the use of next-generation sequencing for the first stage [e.g., Nejentsev et al., 2009] has not previously been explored to the same degree.”
MethodMaiti, A. K., Kim-Howard, X., Viswanathan, P., Guillén, L., Rojas‐Villarraga, A., Deshmukh, H., Direskeneli, H., Saruhan‐Direskeneli, G., Cañas, C. A., Tobón, G. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27222 · Cited by 96
“We used CATS software (36) for power calculation.”
Consortium analysis of 7 candidate SNPs for ovarian cancer
Ramus, S. J., Vierkant, R. A., Johnatty, S. E., Pike, M. C., Berg, D. J. V. D., Wu, A. H., Pearce, C. L., Menon, U., Gentry‐Maharaj, A., Gayther, S. A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23448 · Cited by 88
“a combined analysis with adjustment for multiple testing has more power than a replication analysis.(41) Neither RB1 nor AURKA were”
MethodHTR2A gene variation is involved in antidepressant treatment response
Lucae, S., Ising, M., Horstmann, S., Baune, B. T., Arolt, V., Müller-Myhsok, B., Holsboer, F., & Domschke, K. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.08.006 · Cited by 85
Multi-ancestry meta-analysis and fine-mapping in Alzheimer’s disease
Lake, J., Solsberg, C. W., Kim, J. J., Acosta‐Uribe, J., Makarious, M. B., Li, Z., Levine, K. S., Heutink, P., Alvarado, C. X., Vitale, D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02089-w · Cited by 90
“All SNPs in the 99% credible sets were annotated with VEP (http:// grch37.ensembl.org/Homo_sapiens/Tools/VEP) using default criteria to select one block of annotation per variant (Table S4).”
MethodA Common Variant in DRD3 Receptor Is Associated with Autism Spectrum Disorder
de Krom, M., Staal, W., Ophoff, R. A., Hendriks, J., Buitelaar, J. K., Franke, B., de Jonge, M. V., Bolton, P., Collier, D. A., Curran, S. R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.035 · Cited by 91
Park, S. K., Tao, Y., Meeker, J. D., Harlow, S. D., & Mukherjee, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098632 · Cited by 91
Persico, M., Capasso, M., Russo, R., Persico, E., Crocè, L. S., Tiribelli, C., & Iolascon, A. (2007) · Gut · doi:10.1136/gut.2007.129478 · Cited by 88
Beyond Endometriosis Genome-Wide Association Study: From Genomics to Phenomics to the Patient
Rahmioglu, N., Morris, A., Nyholt, D., Montgomery, G., Becker, C., Missmer, S., & Zondervan, K. (2016) · Seminars in Reproductive Medicine · doi:10.1055/s-0036-1585408 · Cited by 84
Moore, C. M., Jacobson, S. A., & Fingerlin, T. E. (2019) · Human Heredity · doi:10.1159/000508558 · Cited by 84
Controlling false discoveries in genetic studies
van den Oord, E. J. C. G. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30650 · Cited by 82
Meta-Analysis in Genome-Wide Association Datasets: Strategies and Application in Parkinson Disease
Evangelou, E., Maraganore, D. M., & Ioannidis, J. P. A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000196 · Cited by 83
Bonnycastle, L. L., Willer, C. J., Conneely, K. N., Jackson, A. U., Burrill, C. P., Watanabe, R. M., Chines, P. S., Narisu, N., Scott, L. J., Enloe, S. T., et al. (2006) · Diabetes · doi:10.2337/db06-0178 · Cited by 81
“This strategy of joint analysis has greater power than a replication study in which only the results for the second sample are considered (30).”
BackgroundMethodSelf-citationGAS Power Calculator: web-based power calculator for genetic association studies
Johnson, J. L., & Abecasis, G. R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/164343 · Cited by 74
Self-citationConvergence of Genome‐Wide Association and Candidate Gene Studies for Alcoholism
Olfson, E., & Bierut, L. J. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01843.x · Cited by 90
“The power Calculator for Association (CATS) was used to determine what effect sizes the SAGE data set is able to detect (Skol et al., 2006).”
Bossini‐Castillo, L., Martín, J., Broen, J. C. A., Gorlova, O. Y., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Callejas-Rubio, J. L., Castellvi, I., Carreira, P. E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr522 · Cited by 85
“Power was calculated using the software Power Calculator for Genetic Studies 2006 (46) and assuming an additive model (P-value 1⁄4 0.”
MethodMeng, W., Adams, M. J., Hébert, H. L., Deary, I. J., McIntosh, A. M., & Smith, B. H. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.023 · Cited by 86
Genome-Wide Association Study of Peripheral Artery Disease
van Zuydam, N. R., Stiby, A., Abdalla, M., Austin, E., Dahlström, E. H., McLachlan, S., Vlachopoulou, E., Ahlqvist, E., Di Liao, C., Sandholm, N., et al. (2021) · Circulation: Genomic and Precision Medicine · doi:10.1161/circgen.119.002862 · Cited by 80
Helmstaedter, C., Mihov, Y., Toliat, M. R., Thiele, H., Nuernberg, P., Schoch, S., Surges, R., Elger, C. E., Kunz, W. S., & Hurlemann, R. (2013) · Epilepsia · doi:10.1111/j.1528-1167.2012.03603.x · Cited by 82
“Finally, to increase statistical power, genetic association was tested through a joint meta-analysis (Skol et al., 2006; Terracciano et al., 2010).”
BackgroundMethodInfluentialChristie, J. D., Wurfel, M. M., Feng, R., O'Keefe, G. E., Bradfield, J., Ware, L. B., Christiani, D. C., Calfee, C. S., Cohen, M. J., Matthay, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028268 · Cited by 82
Jannot, A., Ehret, G., & Perneger, T. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.01.001 · Cited by 91
Association study of IL10 and IL23R–IL12RB2 in Iranian patients with Behçet's disease
Xavier, J. M., Shahram, F., Davatchi, F., Rosa, A., Crespo, J., Abdollahi, B. S., Nadji, A., Jesus, G., Barcelos, F., Patto, J. V., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34437 · Cited by 83
Genetic influences on susceptibility to rheumatoid arthritis in African-Americans
Laufer, V. A., Tiwari, H. K., Reynolds, R. J., Danila, M. I., Wang, J., Edberg, J. C., Kimberly, R. P., Kottyan, L. C., Harley, J. B., Mikuls, T. R., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddy395 · Cited by 78
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Joseph, J., Liu, C., Hui, Q., Aragam, K. G., Wang, Z., CHAREST, B. R., Huffman, J. E., Keaton, J. M., Edwards, T. L., Demissie, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35323-0 · Cited by 86
“(25) Joint meta-analysis results were reported for unclassified HF to improve the power for GWAS discovery.(26) GWAS results were summarized using FUMA, a”
MethodKonings, A., Laer, L. V., Wiktorek-Smagur, A., Rajkowska, E., Pawelczyk, M., Carlsson, P., Bondeson, M.-L., Dudarewicz, A., Vandevelde, A., Fransén, E., et al. (2009) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2008.00499.x · Cited by 81
“This method was preferred since it has been shown that a joint analysis of the data from both phases of a two-stage association study almost always results in an increased power to detect genetic association (Skol et al., 2006).”
MethodMeng, W., Shah, K. P., Pollack, S. J., Toppila, I., Hébert, H. L., McCarthy, M. I., Groop, L., Ahlqvist, E., Lyssenko, V., Agardh, E., et al. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13769 · Cited by 83
Graw, S., Henn, R., Thompson, J. A., & Koestler, D. C. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2804-7 · Cited by 80
Huang, W., Kirkpatrick, B. W., Rosa, G. J. M., & Khatib, H. (2010) · Animal Genetics · doi:10.1111/j.1365-2052.2010.02046.x · Cited by 80
Bossini‐Castillo, L., Broen, J. C. A., Simeón‐Aznar, C. P., Beretta, L., Vonk, M. C., Ortego‐Centeno, N., Espinosa, G., Carreira, P. E., Camps, M. T., Navarrete‐Navarrete, N., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.141838 · Cited by 80
Everson, T. M., Lyons, G., Zhang, H., Soto-Ramírez, N., Lockett, G. A., Patil, V. K., Merid, S. K., Sӧderhӓll, C., Melén, E., Holloway, J. W., et al. (2015) · Genome Medicine · doi:10.1186/s13073-015-0213-8 · Cited by 78
“We implemented a two-stage genome-wide approach [30]: stage 1 analyses selected a set of atopycandidate loci from genome-wide DNA-M within a subsample (n = 245), and stage 2 analyses tested those loci for associations with atopy and an alternate”
MethodBossini‐Castillo, L., de Kovel, C. G. F., Källberg, H., Slot, R. V. ‘., Italiaander, A., Coenen, M. J. H., Tak, P. P., Posthumus, M. D., Wijmenga, C., Huizinga, T. W. J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204591 · Cited by 78
Salie, M., Daya, M., Lucas, L. A., Warren, R. M., van der Spuy, G. D., van Helden, P. D., Hoal, E. G., & Möller, M. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.07.004 · Cited by 84
“With regards to the power of our study to detect an association we used the CaTS Power Calculator (Skol et al., 2006).”
MethodGenome-wide association study identifies two risk loci for tuberculosis in Han Chinese
Zheng, R., Li, Z., He, F., Liu, H., Chen, J., Chen, J., Xie, X., Zhou, J., Chen, H., Wu, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06539-w · Cited by 84
Huffman, J. E., de Vries, P. S., Morrison, A. C., Sabater‐Lleal, M., Kacprowski, T., Auer, P. L., Brody, J. A., Chasman, D. I., Chen, M., Guo, X., et al. (2015) · Blood · doi:10.1182/blood-2015-02-624551 · Cited by 84
van Dijk, E. H. C., Schellevis, R. L., van Bergen, M. G. J. M., Breukink, M. B., Altay, L., Scholz, P., Fauser, S., Meijer, O. C., Hoyng, C. B., den Hollander, A. I., et al. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.0245 · Cited by 78
Mola-Caminal, M., Carrera, C., Soriano‐Tárraga, C., Steinhauer, E. G., Navarro, R. D., Tur, S., Jiménez, C., Medina-Dols, A., Cullell, N., Torres‐Aguila, N. P., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313533 · Cited by 76
Chiari Malformation Type I: A Case-Control Association Study of 58 Developmental Genes
Urbizu, A., Toma, C., Poca, M. A., Sahuquillo, J., Cuenca-León, E., Cormand, B., & Macaya, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057241 · Cited by 85
“edu/csg/ abecasis/CaTS) [57], assuming an odds ratio (OR) of 1.”
BackgroundLewinger, J. P., Conti, D. V., Baurley, J. W., Triche, T. J., & Thomas, D. C. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20248 · Cited by 77
“Furthermore, the Bayesian framework provides a natural way to use the results of an earlier scan as priors in analyzing the later stage data, rather than a formal combined analysis of the raw data from both as is usually recommended [Satagopan and Elston, 2003; Skol et al., 2006; Wang et al., 2006].”
MethodPower and sample size calculations for fMRI studies based on the prevalence of active peaks
Durnez, J., Degryse, J., Moerkerke, B., Seurinck, R., Sochat, V., Poldrack, R. A., & Nichols, T. E. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/049429 · Cited by 69
“One of these possibilities is the development of a testing procedure that would allow to use the pilot data in the final study without harming the false positive rate (see, e.g., similar ideas in genetics Skol et al. 2006).”
Guo, T., McDonald-McGinn, D., Blonska, A., Shanske, A., Bassett, A. S., Chow, E., Bowser, M., Sheridan, M., Beemer, F., Devriendt, K., et al. (2011) · Human Mutation · doi:10.1002/humu.21568 · Cited by 72
“Power calculations for CHD associations were performed using the CaTS Genetic Power Calculator (http://www.sph.umich.edu/csg/ abecasis/CaTS/index.html) [Skol et al., 2006].”
MethodMaiti, A. K., Kim-Howard, X., Viswanathan, P., Guillen, L., Qian, X., Rojas‐Villarraga, A., Sun, C., Cañas, C. A., Tobón, G. J., Matsuda, K., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep470 · Cited by 75
Steer, S. E., Abkevich, V., Gutin, A., Cordell, H. J., Gendall, K. L., Merriman, M. E., Rodger, R. A., Rowley, K. A., Chapman, P. T., Gow, P. J., et al. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364359 · Cited by 78
Jia, X., Yamamura, T., Gbadegesin, R., McNulty, M. T., Song, K., Nagano, C., Hitomi, Y., Lee, D., Aiba, Y., Khor, S., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.029 · Cited by 77
“The power of discovery GWAS (987 cases and 3206 controls) was calculated using the R package “CATS”.55 Assuming a disease prevalence of 0.016%, study power was calculated separately under the additive model for variants with an allele frequency of 0.5%, 5%, and 50%, with a significance threshold a ¼ 5E–08 (Supplementa…”
MethodInfluentialMachine Learning and Radiogenomics: Lessons Learned and Future Directions
Kang, J., Rancati, T., Lee, S., Oh, J. H., Kerns, S. L., Scott, J. G., Schwartz, R. S., Kim, S. Y., & Rosenstein, B. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00228 · Cited by 76
“, a replication study), but power is unable to exceed that of one-stage GWAS (137).”
BackgroundJia, X., Horinouchi, T., Hitomi, Y., Shono, A., Khor, S., Omae, Y., Kojima, K., Kawai, Y., Nagasaki, M., Kaku, Y., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017080859 · Cited by 74
den Dekker, H. T., Burrows, K., Felix, J. F., Salas, L. A., Nedeljkovic, I., Yao, J., Rifas‐Shiman, S. L., Ruiz-Arenas, C., Amin, N., Bustamante, M., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.01795-2018 · Cited by 76
Quality Control Procedures for Genome‐Wide Association Studies
Truong, V. Q., Woerner, J., Cherlin, T., Bradford, Y., Lucas, A., Okeh, C. C., Shivakumar, M., Hui, D. H., Kumar, R., Pividori, M., et al. (2022) · Current Protocols · doi:10.1002/cpz1.603 · Cited by 74
Bei, J., Jia, W.-H., & Zeng, Y.-X. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.012 · Cited by 78
Metadata
- Authors
- Skol, A. D., Scott, L. J., Abecasis, G. R., & Boehnke, M.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Boehnke, Michael
- Venue
- Nature Genetics
- Published
- 2006-01-15
- Volume
- 38
- Issue
- 2
- Pages
- 209-213
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2140126911
- Cited by
- 1,286
- References
- 21
- Citations by year
- 2026: 7 · 2025: 32 · 2024: 35 · 2023: 32 · 2022: 36 · 2021: 45 · 2020: 47 · 2019: 56 · 2018: 55 · 2017: 76 · 2016: 65 · 2015: 52 · 2014: 70 · 2013: 69 · 2012: 95
- FWCI
- 61.77
- Type
- journal article
- Language
- en
- Update notices
- erratum (2006-03-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Forensic and Genetic Research
- Keywords
- joint analysis, statistical power, sample allocation, marker selection, effect size heterogeneity, significance level
- MeSH terms
- Alleles, DNA Replication, Gene Frequency, Genetic Markers, Genetics, Medical, Genotype, Humans, Genome, Human, Case-Control Studies, Genetic Heterogeneity, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.